TNFA - Total Utang marang Modal TNF Pharmaceuticals, Inc.

TNF Pharmaceuticals (TNFA) is restructuring its assets to focus on developing treatments for immunometabolic pathologies, with commercial success contingent upon clinical trial stages. The company has optimized its biomaterial analysis processes through the implementation of artificial intelligence. This price chart reflects a debt-to-equity ratio of 0.00. The business develops TNF inhibitors, banking on patent protection and potential acquisition by pharma behemoths.

TNFA: Total Utang marang Modal TNF Pharma 25.07.2024 - 25.09.2025

Rincian analitis perusahaan TNF Pharmaceuticals

- rega lan prakiraan konsensus rega:
Bagan rega TNF Pharmaceuticals Inc.|TNFA - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar TNF Pharmaceuticals|TNFA - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham TNF Pharmaceuticals|TNFA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku tnfpharma.com|TNFA - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas TNF Pharmaceuticals|TNFA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal TNF Pharmaceuticals Inc.|TNFA - Gunggung utang perusahaan|Utang marang nilai buku TNF Pharmaceuticals|TNFA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TNF Pharmaceuticals|Indikator likuiditas cepet tnfpharma.com
- informasi bathi lan kelipatan valuasi:
TNFA - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:TNF Pharmaceuticals

For TNF Pharmaceuticals (TNFA), which invests in the development of anti-aging and anti-inflammatory molecules, the leverage ratio—the relationship between total debt and equity—reflects the balance between borrowed funds and owned assets. This metric measures the proportion of liabilities within the financing structure, allowing investors to assess the risk of a cash gap should loan growth outpace revenue dynamics and capitalization.

Analisis pesaing TNF Pharmaceuticals

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Oramed Pharmaceuticals Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal ENTX (Entera Bio Ltd)|HYFT - Utang marang Ekuitas|ABVC (ABVC BioPharma, Inc) - Rasio Utang marang Ekuitas|CPIX: Total Utang marang Modal|Utang Agregat marang Ekuitas QNTM (quantumbiopharma.com)|Rasio Total Utang marang Ekuitas FGEN|TELO: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Rani Therapeutics (RANI)|SNYR: Utang Agregat marang Ekuitas|Total Utang marang Modal RLYB (Rallybio)|Rasio Kabeh Utang marang Dana Pribadi LEXX|Pulmatrix - Total Utang marang Modal|PTHL - Total Utang marang Modal|aptorumgroup.com (APM) - Utang marang Ekuitas|Lyra Therapeutics Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Impact BioMedical Inc|Rasio Total Utang marang Ekuitas cbdMD Corp (YCBD)|Total Utang marang Modal PRFX|Total Utang marang Modal altamiratherapeutics.com (CYTO)|Total Utang marang Modal LIPO (Lipella)|OPTN - Rasio Total Utang marang Ekuitas|Pieris Pharmaceuticals - Total Utang marang Modal|Utang marang Modal procapsgroup.com|PTPI (Petros Pharmaceuticals, Inc.) - Rasio Total Utang marang Ekuitas|Qilian International Holding Group (QLI) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas SLRN|TFFP (TFF Pharmaceuticals, Inc) - Utang Agregat marang Modal